Lower back pain market which was USD 8,812.01 million in 2021, would rocket up to USD 13421.46 million by 2029, and is expected to undergo a CAGR of 5.40% during the forecast period 2022 to 2029.

Lower Back Pain Market Analysis and Size
Acute low back pain can be treated for the underlying reason or the initial damage, but chronic low back pain must last for 12 weeks or more. Chronic low back pain is lower back discomfort that lasts longer than three months. This condition can be caused by an injury, illness, or stress on various body parts. The pain can vary greatly and manifest as bone pain, muscle pain, or nerve pain.
Data Bridge Market Research analyses that the lower back pain market which was USD 8,812.01 million in 2021, would rocket up to USD 13421.46 million by 2029, and is expected to undergo a CAGR of 5.40% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Nearly everyone has experienced lower back discomfort at some point. Basically, it is a sort of muscle tension, pain, or rigidity that is present above the gluteal sulcus and below the bottom margin of the rib cage. It may be brought on by a strain (injury) to the back's muscles or tendons, arthritis, structural issues, or disc injuries. There are three different types of low back pain: acute, subacute, and chronic.

Lower Back Pain Market Dynamics
Drivers

Increase in nerve cases
Demand for the lower back pain market is anticipated to be driven by an inactive lifestyle and an increase in nerve cases. The increased use of novel antidepressants and the rising elderly population are additional significant factors driving the market's expansion. Within the forecast period, the market is expected to experience new, attractive growth prospects due to rising research and development, particularly in the area of lower back pain.

Rise in anti-inflammatory medications
Anti-inflammatory medications' negligible adverse effects are encouraging a rise in their use as painkillers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as non-steroidal anti-inflammatory treatments is aiding the industry's growth. Additionally, the lower doses of these medications are commonly accessible without a doctor's prescription. The market for lower back pain is anticipated to rise as a result of market participants' efforts to create novel NSAIDs that would lessen patients' pain.

Rising number of individuals
The expansion of the market is being aided by the rising number of individuals in the area who suffer from persistent lower back pain. The market growth for chronic lower back pain treatment in North America is quickening due to rising healthcare spending by the populace and the presence of cutting-edge healthcare infrastructure. In the upcoming years, it is projected that growing research efforts to identify the root causes of chronic lower back pain and create better treatment alternatives will spur market expansion.

Opportunities

The primary growth drivers for the chronic lower back pain market are an increase in the frequency of nerve instances and an increase in the senior population. For instance, the National Institute of Neurological disorders and stroke reports that roughly 80% of adults have this type of low back discomfort at some point in their lives. Inactivity, expanding healthcare awareness in developed and developing nations, and rising consumer disposable income are further factors anticipated to promote market expansion.

Restraints/Challenges

On the other hand, the high cost associated with drug development will obstruct the market's growth rate. The stringent regulatory policies will also restrain the market growth rate during the forecast period of 2022-2029.

This lower back pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lower back pain market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Request access for free sample report : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lower-back-pain-market
Lower Back Pain Market Regional Analysis/Insights
The countries covered in the lower back pain market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Lower Back Pain Market Share Analysis
Some of the major players operating in the lower back pain market are:
• Pfizer Inc (U.S.)
• Johnson & Johnson Private Limited (U.S.)
• Sanofi (France)
• Endo Pharmaceuticals Inc. (Ireland)
• Merck & Co Inc. (U.S.)
• Dr. Reddy's Laboratories Ltd. (India)
• Vertebral Technologies, Inc. (U.S.)
• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• BioWave Corporation
• Koninklijke Philips N.V. (Netherlands)
Get full access of the report: https://www.databridgemarketresearch.com/reports/global-lower-back-pain-market
MAJOR TOC OF THE REPORT
• Chapter One: Introduction
• Chapter Two: Market Segmentation
• Chapter Three: Market Overview
• Chapter Four: Executive Summary
• Chapter Five: Premium Insights
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=global-lower-back-pain-market
Top Trending Reports:
https://hiotron-india.blogspot.com/2023/03/lower-back-pain-market-which-was-usd_31.html

https://hiotron-india.blogspot.com/2023/03/liquid-egg-processing-market-growing-to.html

https://hiotron-india.blogspot.com/2023/03/fish-protein-market-industry-trends-and_31.html

https://hiotron-india.blogspot.com/2023/03/almond-protein-market-by-product-and.html

https://hiotron-india.blogspot.com/2023/03/europe-personal-care-ingredients_31.html

Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.